The incidence of thyroid dysfunction in children who have been given diagnostic 123I-MIBG for suspected neuroblastoma.

The incidence of thyroid dysfunction in children who have been given diagnostic 123I-MIBG for suspected neuroblastoma. - Thyroid function after the use of diagnostic 123I-MIBG

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41559

Enrollment

100

Registered

2013-03-04

Start date

2013-03-27

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidism thyroid dysfunction

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Children and young adults who received diagnostic 123I-MIBG for suspected neuroblastoma

Exclusion criteria

Exclusion criteria: Children and young adults who received therapeutic 131I-MIBG

Design outcomes

Primary

Measure	Time frame
The end-points are TSH, FT4.	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results